11 – 20 of 76
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2020
- 
                        Mark
        Early growth response 1 regulates hematopoietic support and proliferation in human primary bone marrow stromal cells
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study : high white blood cell count at diagnosis is the strongest prognostic factor
    
    - Contribution to journal › Article
 
- 
                        Mark
        Endothelial protein C receptor (EPCR) expression marks human fetal liver hematopoietic stem cells
    
    - Contribution to journal › Article
 
- 
                        Mark
        First line therapy in chronic lymphocytic leukemia : a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013
    
    - Contribution to journal › Article
 
- 
                        Mark
        Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia
    
    - Contribution to journal › Article
 
- 
                        Mark
        Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells
    
    - Contribution to journal › Article
 
- 
                        Mark
        Mode of delivery in hemophilia : Vaginal delivery and Cesarean section carry similar risks for intracranial hemorrhages and other major bleeds
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Acute myeloid leukemia in very old patients
    
    - Contribution to journal › Article
 
- 
                        Mark
        Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma
    
    - Contribution to journal › Letter
 
- 2017
- 
                        Mark
        Distinct global binding patterns of the Wilms' tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells
    
    - Contribution to journal › Article
 
